Literature DB >> 2457449

Identification of a uveitopathogenic and lymphocyte proliferation site in bovine S-antigen.

V K Singh1, R B Nussenblatt, L A Donoso, K Yamaki, C C Chan, T Shinohara.   

Abstract

S-antigen is a well-characterized retinal protein that is highly pathogenic for the induction of experimental autoimmune uveitis (EAU), a severe inflammatory disease of the eye and the pineal gland. EAU was observed following the immunization of Lewis rats with various doses (50 to 200 micrograms) of a small synthetic peptide, peptide N (22 amino acids in length), which corresponds to amino acid positions 281 to 302 in bovine S-antigen. Peptide N consistently induced an EAU that was identical to the disease caused by native S-antigen. Clinically, the disease that developed in the eye was characterized by iris and pericorneal hyperemia, followed by inflammatory exudates in the anterior chamber and vitreous. Histopathologically, a severe inflammatory response was observed that resulted in the complete destruction of the photoreceptor cell layer of the retina. In addition, animals with ocular inflammatory disease had an associated pinealitis characterized by a lymphocytic infiltration of the pineal gland. Furthermore, draining lymph node cells of rats immunized with peptide N showed strong in vitro proliferative responses toward peptide N as measured by [3H]thymidine uptake. Our results indicate that several synthetic peptides, which correspond to the amino acid sequence of bovine S-antigen, are capable of inducing an EAU and, as such, suggest that multiple uveitopathogenic sites may be present in the molecule.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2457449     DOI: 10.1016/0008-8749(88)90193-1

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  12 in total

Review 1.  The natural history of uveitis.

Authors:  R B Nussenblatt
Journal:  Int Ophthalmol       Date:  1990-10       Impact factor: 2.031

2.  Cellular immune responses to retinal antigens in retinitis pigmentosa.

Authors:  J H Yamamoto; O Okajima; M Mochizuki; T Shinohara; B Wiggert; G J Chader; I Gery; R B Nussenblatt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

3.  Rodent models of experimental autoimmune uveitis.

Authors:  Rajeev K Agarwal; Phyllis B Silver; Rachel R Caspi
Journal:  Methods Mol Biol       Date:  2012

Review 4.  Cytokines in posterior uveitis: an update.

Authors:  V K Singh; G Rai
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 5.  Experimental autoimmune uveitis: molecular mimicry and oral tolerance.

Authors:  V K Singh; K Nagaraju
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

6.  Cellular autoimmunity to retinal specific antigens in patients with Behçet's disease.

Authors:  J H Yamamoto; M Minami; G Inaba; K Masuda; M Mochizuki
Journal:  Br J Ophthalmol       Date:  1993-09       Impact factor: 4.638

7.  Cellular immune responses of patients with juvenile chronic arthritis to retinal antigens and their synthetic peptides.

Authors:  D Gupta; V K Singh; J Rajasingh; T Shinohara; R Misra; S S Agarwal
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

8.  Cellular immune response of patients with uveitis to peptide M, a retinal S-antigen fragment.

Authors:  S Nityanand; V K Singh; T Shinohara; A K Paul; V Singh; P K Agarwal; S S Agarwal
Journal:  J Clin Immunol       Date:  1993-09       Impact factor: 8.317

Review 9.  Experimental autoimmune uveoretinitis (EAU) versus experimental allergic encephalomyelitis (EAE): a comparison of T cell-mediated mechanisms.

Authors:  V L Calder; S L Lightman
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

10.  Effective Arrestin-Specific Immunotherapy of Experimental Autoimmune Uveitis with RTL: A Prospect for Treatment of Human Uveitis.

Authors:  Madison Kyger; Aneta Worley; Jianya Huan; Hugh McDowell; W Clay Smith; Gregory G Burrows; Mary J Mattapallil; Rachel R Caspi; Grazyna Adamus
Journal:  Transl Vis Sci Technol       Date:  2013-02-05       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.